With proven results including cost savings and improved patient outcomes in more than 20 leading health systems, Carta Healthcare will use the funds to scale its business
Carta Healthcare®, a pioneer in harnessing the power of clinical data, today announced it closed a $20 million series B round, with investors including Paramark Ventures, Frist Cressey Ventures, American College of Cardiology, Asset Management Ventures, CU Healthcare Innovation Fund, Mass General Brigham, Maverick Ventures Investment Fund, and Storm Ventures.
Carta Healthcare currently serves 16 of the leading health systems in the United States, including Stanford University Medical Center, Common Spirit, UCSF, Mass General Brigham, to name a few. Carta Healthcare’s industry-leading solutions reduce the cost of labor associated with manual data abstraction processes and curate trustworthy, actionable datasets concerning patient care. By transforming the abstraction process and implementing powerful analytic capabilities, Carta Healthcare informs data-driven decisions that improve patient outcomes, realize equipment and data processing cost savings, and enable healthcare professionals to spend more time on patient care rather than data entry.
Matt Hollingsworth, Co-Founder and CEO
“Carta Healthcare is incredibly excited and thankful for this funding round, which will help us scale the business and further realize our mission to make healthcare more accessible, efficient, scalable, effective, and affordable for patients across the United States,” said Matt Hollingsworth, co-founder and CEO at Carta Healthcare. “We look forward to continually helping reduce the administrative burden and data entry fatigue among healthcare workers so they can spend their time and energy on research and face-to-face patient time and share best practices to improve patient outcomes.”
Lucas Tanner, CFO
“At Carta Healthcare, we believe that the highest attainable standard of health is a fundamental right of every human being. Since our Series A in April 2021, we have been able to help leading health systems process and analyze data quickly, accurately, and insightfully to improve on the delivery of care. With our Series B round of funding, we will be able to focus on rapidly expanding our solutions to help even more hospitals cost effectively improve patient outcomes.”
To learn more about how innovative solutions, including those that Carta Healthcare’s interdisciplinary team of experts has created, can address common healthcare challenges, listen to our new podcast, Charting the Waters, or visit www.carta.healthcare.
About Carta Healthcare
Founded in 2017, Carta Healthcare’s mission is to improve patient care by harnessing the value of clinical data. Through its combination of industry-leading, AI-driven technology, and multidisciplinary team of experts, Carta Healthcare has transformed the traditional clinical data abstraction process. The company’s agile, innovative approach to expertise and technology allows healthcare organizations to collect, analyze, and act on their clinical and operational data in a fraction of the time. The result is high-quality, accurate, trustworthy datasets for use across a healthcare organization’s initiatives to operate more efficiently, optimize care delivery, improve patient outcomes, and allow clinicians to practice at the top of their license. For more information, check out our new podcast, Charting the Waters; visit www.carta.healthcare; or contact us at hello@carta.healthcare.
Originally announced November 2nd, 2022
